Gene: Nat8f2 (N-acetyltransferase 8 (GCN5-related) family member 2) Mus musculus
Analyze
Symbol:
Nat8f2
Name:
N-acetyltransferase 8 (GCN5-related) family member 2
RGD ID:
1623877
MGI Page
MGI
Description:
Predicted to have N-acetyltransferase activity. Predicted to be involved in negative regulation of cell adhesion. Predicted to localize to Golgi apparatus and endoplasmic reticulum. Is expressed in brain; genitourinary system; liver; and respiratory system. Orthologous to human NAT8 (N-acetyltransferase 8 (putative)); INTERACTS WITH 2,2',4,4',5,5'-hexachlorobiphenyl; 2,2',5,5'-tetrachlorobiphenyl; 2,3,7,8-tetrachlorodibenzodioxine.
Type:
protein-coding
RefSeq Status:
VALIDATED
Also known as:
camello-like 2; camello-like protein 2; Cml; cml2; N-acetyltransferase family 8 member 2; N-acetyltransferase-like protein CML2; probable N-acetyltransferase CML2
RGD Orthologs
Alliance Genes
More Info
more info ...
More Info
Latest Assembly:
GRCm38 - Mouse Genome Assembly GRCm38
Position:
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 6 85,842,404 - 85,846,119 (-) NCBI GRCm39 mm39 GRCm38 6 85,865,422 - 85,869,137 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 6 85,865,422 - 85,869,158 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 6 85,815,416 - 85,819,131 (-) NCBI GRCm37 mm9 NCBIm37 MGSCv36 6 85,831,056 - 85,834,792 (-) NCBI mm8 Celera 6 59,929,246 - 59,932,961 (+) NCBI Celera Cytogenetic Map 6 C3 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
1-naphthyl isothiocyanate decreases expression ISO RGD:1561619 6480464 1-Naphthylisothiocyanate results in decreased expression of NAT8F2 mRNA CTD PMID:30723492 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of NAT8F2 mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of NAT8F2 mRNA CTD PMID:26377647 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:1561619 6480464 [3 more ... CTD PMID:30744511 3,3',4,4'-tetrachlorobiphenyl multiple interactions EXP 6480464 3 more ... CTD PMID:19467301 3,4,5,3',4',5'-Hexachlorobiphenyl multiple interactions ISO RGD:1561619 6480464 [3 more ... CTD PMID:30744511 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of NAT8F2 mRNA CTD PMID:28973697 acrylamide increases expression ISO RGD:1561619 6480464 Acrylamide results in increased expression of NAT8F2 mRNA CTD PMID:28959563 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of NAT8F2 mRNA CTD PMID:19770486 benzo[a]pyrene decreases expression EXP 6480464 Benzoapyrene results in decreased expression of NAT8F2 mRNA CTD PMID:19770486 beta-naphthoflavone multiple interactions EXP 6480464 AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of NAT8F2 mRNA] CTD PMID:22234961 beta-naphthoflavone decreases expression EXP 6480464 beta-Naphthoflavone results in decreased expression of NAT8F2 mRNA CTD PMID:22234961 buta-1,3-diene decreases expression EXP 6480464 1, 3-butadiene results in decreased expression of NAT8F2 mRNA CTD PMID:29038090 carbon nanotube increases expression EXP 6480464 Nanotubes, Carbon results in increased expression of NAT8F2 mRNA CTD PMID:25620056 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of NAT8F2 mRNA CTD PMID:20938992 clofibrate multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of NAT8F2 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of NAT8F2 mRNA] CTD PMID:17585979 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of NAT8F2 mRNA CTD PMID:19770486 folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of NAT8F2 mRNA CTD PMID:20938992 furan increases expression ISO RGD:1561619 6480464 furan results in increased expression of NAT8F2 mRNA CTD PMID:25539665 furan decreases expression ISO RGD:1561619 6480464 furan results in decreased expression of NAT8F2 mRNA CTD PMID:25539665 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of NAT8F2 mRNA CTD PMID:20938992 ochratoxin A increases expression ISO RGD:1561619 6480464 ochratoxin A results in increased expression of NAT8F2 mRNA CTD PMID:30449730 orphenadrine affects expression ISO RGD:1561619 6480464 Orphenadrine affects the expression of NAT8F2 mRNA CTD PMID:23665939 paracetamol multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of NAT8F2 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of NAT8F2 mRNA] CTD PMID:17585979 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of NAT8F2 mRNA CTD PMID:17562736 PCB138 multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of NAT8F2 mRNA CTD PMID:17426115 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of NAT8F2 mRNA CTD PMID:18445702 , PMID:23811191 propiconazole decreases expression EXP 6480464 propiconazole results in decreased expression of NAT8F2 mRNA CTD PMID:21278054 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of NAT8F2 mRNA CTD PMID:31919559 thioacetamide decreases expression ISO RGD:1561619 6480464 Thioacetamide results in decreased expression of NAT8F2 mRNA CTD PMID:23411599 tunicamycin decreases expression EXP 6480464 Tunicamycin results in decreased expression of NAT8F2 mRNA CTD PMID:17127020 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of NAT8F2 mRNA CTD PMID:17292431